1. Bronchiactesis is a 250k patient pop and the next indication for Arikace
2. Iplex will find its niche before anyone expects
3. Shorts are just beginning to feel the squeeze
4. Yesterday's action alerted all the traders to a strong move in the making
5. Biotech cosolidation is ramping up
6. Lewis dropped several golden nuggets last Friday about Arikace effectiveness
7. Increlex needs an upgrade, really needs it!